# Pierluigi Viale

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pierluigi-viale/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,813 |
| Field | Antibiotic Resistance in Bacteria |
| h-index | 79 |
| i10-index | 418 |
| Last Known Institution | Azienda USL di Bologna |
| OpenAlex ID | https://openalex.org/A5045135007 |
| ORCID iD | 0000-0003-1264-0008 |
| Works | 722 |

## Researcher papers

Showing 12 of 13.

- [Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy](https://scholariq.org/papers/predictors-of-mortality-in-bloodstream-infections-caused-by-klebsiella/)
- [Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study](https://scholariq.org/papers/effect-of-appropriate-combination-therapy-on-mortality-of-patients-with/)
- [Infections caused by KPC-producing <i>Klebsiella pneumoniae</i> : differences in therapy and mortality in a multicentre study](https://scholariq.org/papers/infections-caused-by-kpc-producing-i-klebsiella-pneumoniae-i-differences-in/)
- [Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study](https://scholariq.org/papers/epidemiology-of-invasive-pulmonary-aspergillosis-among-intubated-patients-with/)
- [Age and Multimorbidity Predict Death Among COVID-19 Patients](https://scholariq.org/papers/age-and-multimorbidity-predict-death-among-covid-19-patients/)
- [Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses](https://scholariq.org/papers/remdesivir-and-three-other-drugs-for-hospitalised-patients-with-covid-19-final/)
- [Hospital-Acquired Infections in Critically Ill Patients With COVID-19](https://scholariq.org/papers/hospital-acquired-infections-in-critically-ill-patients-with-covid-19/)
- [2016 WSES guidelines on acute calculous cholecystitis](https://scholariq.org/papers/2016-wses-guidelines-on-acute-calculous-cholecystitis/)
- [2017 WSES guidelines on colon and rectal cancer emergencies: obstruction and perforation](https://scholariq.org/papers/2017-wses-guidelines-on-colon-and-rectal-cancer-emergencies-obstruction-and/)
- [Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials](https://scholariq.org/papers/dolutegravir-plus-lamivudine-versus-dolutegravir-plus-tenofovir-disoproxil/)
- [2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients](https://scholariq.org/papers/2019-update-of-the-wses-guidelines-for-management-of-clostridioides-clostridium/)
- [Post COVID-19 irritable bowel syndrome](https://scholariq.org/papers/post-covid-19-irritable-bowel-syndrome/)

## Researcher topics

- [Antibiotic Resistance in Bacteria](https://scholariq.org/topics/antibiotic-resistance-in-bacteria/)
- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)
- [Antibiotic Use and Resistance](https://scholariq.org/topics/antibiotic-use-and-resistance/)
- [Nosocomial Infections in ICU](https://scholariq.org/topics/nosocomial-infections-in-icu/)
- [Antifungal resistance and susceptibility](https://scholariq.org/topics/antifungal-resistance-and-susceptibility/)

## Researcher university

- [Azienda USL di Bologna](https://scholariq.org/institutions/azienda-usl-di-bologna/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.